We serve Chemical Name:nonadecan-10-ol CAS:16840-84-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:nonadecan-10-ol
CAS.NO:16840-84-9
Synonyms:Dinonylcarbinol;10-Nonadecanol;EINECS 240-864-8
Molecular Formula:C19H40O
Molecular Weight:284.52000
HS Code:2905199090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:344.8ºC at 760mmHg
Density:0.836g/cm3
Index of Refraction:1.451
PSA:20.23000
Exact Mass:284.30800
LogP:6.62870
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Dinonylcarbinol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 240-864-8 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,10-Nonadecanol Use and application,Dinonylcarbinol technical grade,usp/ep/jp grade.
Related News: The technology supports breakthroughs in medical research and is widely used by major global pharmaceutical companies to advance drug discovery & development and provide data to support regulatory submissions. nonadecan-10-ol manufacturer The Company��s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA. nonadecan-10-ol supplier Professionally produce and submit DMF files, and supplement data at any time during the patent challenge of formulation companies. nonadecan-10-ol vendor Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs. nonadecan-10-ol factory Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs.
